Liver Cancer Therapeutics Market Growth is Driven by Advancements in Precision Medicine, Immunotherapy and Growing Global Incidence.Pune, Feb. 18, 2025 (GLOBE NEWSWIRE) -- Liver Cancer Therapeutics ...

The FDA approval is based on the results of the open-label KEYNOTE-224 trial, which enrolled 104 patients who had relapsed after or were refractory to Bayer’s Nexavar (sorafenib), the first-line ...

Stock score of Bayer Cropscience Ltd moved down by 1 in 3 months on a 10 point scale (Source: Refinitiv). Get detailed report on Bayer Cropscience Ltd by subscribing to ETPrime.

In the face of an increasing type 1 diabetes population, it is urgent to development more effective and safer T cell-based immunotherapies. Sorafenib tosylate (Nexavar) tablets were purchased from ...